Skip to main content
. 2017 Sep 20;2017:2912763. doi: 10.1155/2017/2912763

Table 1.

Characteristics of the study population.

Parameters ACTH-dependent CS (n = 16) ACTH-independent CS (n = 10) Control (n = 16) p value
Age (years) 44.1 ± 13.5 43.8 ± 9.8 43.9 ± 10.3 0.869
Leukocytes (mm3) 9460.0 ± 2429.2 7508.7 ± 1329.8 5842.0 ± 1279.2 <0.001 ∗∗
Neutrophils (mm3) 6562.5 ± 2093.7 5062.5 ± 1329.8 3270.0 ± 960.4 <0.001 ∗∗
Lymphocytes (mm3) 2031.2 ± 710.6 1725.0 ± 549.6 1870.0 ± 533.4 0.522
Monocytes (mm3) 562.5 ± 224.7 425.0 ± 128.1 330.0 ± 94.8 0.008
T2D (%) 5 (31) 3 (30) 0 (0) 0.341
HTA (%) 8 (50) 5 (50) 0 (0) 0.145
DLP (%) 3 (19) 3(30) 0 (0) 0.271
Obesity (%) 8 (50) 5 (50) 1 (6) 0.215
BMI (kg/m2) 29.4 ± 5.1 29.2 ± 13.1 24.2 ± 4.2 0.339
Waist C (cm) 94.7 ± 14.1 94.2 ± 18.3 77.5 ± 11.7 0.037
WHR 0.90 ± 0.1 0.89 ± 0.1 0.71 ± 0.1 0.024
TC (mmol/l) 5.6 ± 0.8 5.5 ± 0.5 4.5 ± 0.5 0.020
TG (mmol/l) 1.4 ± 0.6 1.4 ± 0.5 0.9 ± 0.6 0.238
LDL-c (mmol/l) 3.4 ± 0.5 3.4 ± 0.6 2.5 ± 0.6 0.016
HDL-c (mmol/l) 1.5 ± 0.4 1.5 ± 0.3 1.7 ± 0.6 0.355
Hs-CRP (mg/dl) 0.36 ± 0.36 0.30 ± 0.31 0.02 ± 0.01 0.038
Glucose (mmol/l) 6.5 ± 2.7 6.1 ± 0.7 5.2 ± 0.6 0.268
HOMA-IR 3.80 ± 2.51 3.69 ± 2.23 2.89 ± 2.91 0.482
HbA1c (DCCT) 6.8 ± 1.9 6.6 ± 0.5 5.4 ± 0.2 0.076
UFC-24hs (mcg/24hs) 269.2 ± 114.8 257.7 ± 118.1 44.8 ± 12.6 0.029
ACTH (pg/ml) 68.4 ± 73.5 5.6 ± 1.4 33.5 ± 7.3 0.023

Data are expressed as mean ± standard deviation. Qualitative variables are expressed as percentages. BMI: body mass index; HOMA-IR: homeostasis model assessment for insulin resistance; T2D: type 2 diabetes; HbA1c (DCCT): haemoglobin A1c (diabetes control and complication trial units); Hs-CRP: high-sensitivity C-reactive protein; LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol; WHR: waist/hip ratio. p < 0.05. ∗∗p < 0.001.